Arkolith/Insider Trading/TRVI/Form 4

Delfini Lisa

Chief Financial OfficerTrevi Therapeutics, Inc. (TRVI) · full profile →Form 4 · filed Jan 10, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2025Option exercise(M)5K$0.51$3K65K
Jan 7, 2025Option exercise(M)1K$0.51$51060K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 8, 2025Option exercise(M)5K—$042K
Jan 7, 2025Option exercise(M)1K—$047K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-004164) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML